<DOC>
	<DOCNO>NCT01401543</DOCNO>
	<brief_summary>This study compare LY2452473 take orally 5 mg capsule time 5 mg tadalafil tablet three different combination tablet ( LY900010 ) 5 mg LY2452473 5 mg tadalafil take orally . The study evaluate amount LY2452473 tadalafil circulate blood treatment . Side effect document . This study approximately 34 day include screening .</brief_summary>
	<brief_title>A Bioavailability Study LY2452473 Tadalafil</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Overtly healthy male , determine medical history physical examination Are body mass index 18.5 30 kg/m² , inclusive screening Have clinical laboratory test result within normal reference range population investigator site , result acceptable deviation judge clinically significant investigator Normal blood pressure heart rate ( HR ; sit ) determine investigator Have venous access sufficient allow blood sampling Are reliable willing make available duration study , abide research unit policy procedures study restriction Have give write informed consent approve Lilly ethical review board ( ERB ) govern site Men must agree use reliable method birth control ( example , vasectomy , condom contraceptive foam , abstinence , female partner 's use oral contraceptive Norplant® ; reliable barrier method birth control [ diaphragm contraceptive jelly ] ; intrauterine device ) , study 1 month follow last dose study drug Have know allergy LY2452473 , tadalafil , related compound History severe allergy multiple adverse drug reaction Have history presence cardiovascular , respiratory , hepatic ( include history cholecystectomy ) , renal , gastrointestinal , endocrine , hematological , neurological disorder capable significantly alter absorption , metabolism , elimination drug ; constitute risk take study medication ; interfere interpretation data Any abnormality 12lead electrocardiogram ( ECG ) opinion investigator place subject unacceptable risk study participation Show evidence significant active neuropsychiatric disease History significant retinal pathology Have history glaucoma Have history unexplained syncope episodes Show evidence hepatitis C and/or positive hepatitis C antibody Show evidence hepatitis B and/or positive hepatitis B surface antigen Show evidence human immunodeficiency virus ( HIV ) and/or positive HIV antibody Intended use overthecounter herbal remedy within 7 day prior dose study Intended use prescription medication within 14 day prior dose study Are willing refrain consumption food , drink beverage contain grapefruit , pomelo , starfruit least 2 week prior start study conclusion Heavy caffeine drinker define regular intake 5 cup coffee ( equivalent xanthinecontaining beverage ) per day subject consistent daily caffeine consumption 1 month prior study entry subject willing maintain consistent caffeine consumption study Use drug abuse , evidence history , and/or positive finding urinary drug screen Have average weekly alcohol intake exceed 14 unit per week unwilling stop alcohol consumption duration study ( 1 unit = 12 oz 360 mL beer ; 5 oz 150 mL wine ; 1.5 oz 45 mL distilled spirit ) Is currently smoker us tobacco product regular basis consistent daily tobacco use 1 month prior study entry subject willing maintain consistent tobacco use study Have history blood donation 1 unit ( approximately 450 mL ) last 3 month prior study entry Have previously complete withdrawn study study investigate LY2452473 Within 30 day initial dose study drug , receive treatment drug receive regulatory approval indication Deemed unsuitable investigator reason Are currently enrol , discontinue within last 30 day , clinical trial involve investigational drug device offlabel use drug device ( study drug/device use study ) , concurrently enrol type medical research judge scientifically medically compatible study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>testosterone</keyword>
	<keyword>energy</keyword>
	<keyword>libido</keyword>
	<keyword>erectile function</keyword>
	<keyword>weak muscle</keyword>
</DOC>